Successful transplants following cardiac death
More lives can be saved now that Israel has adopted technology to allow transplants from donors whose hearts have stopped beating. Previously, some religious authorities rejected brain-stem death, whilst cardiac death damaged vital organs making them unusable.
Wound closure technology saves Israeli soldiers
Soldiers wounded in Operation Protective Edge are benefiting from a brand-new Israeli technology to close open wounds quickly. TopClosure acts like a medical zip to protect wounds immediately when they are inflicted, allowing them to be fully treated later.
Israel pioneers the future of medicine
Electronic Medical Records transformed Israel’s health system and convinced the USA to implement them. Sensing technology is the next big advance. Jerusalem’s symposium “Connected Health and Vulnerable Populations” showed how Israel is a prototype for global better health.
ALS sufferers live longer in Israel
ALS sufferers live longer in Israel. In global terms, between 5 and 10 percent of ALS sufferers survive more than 10 years after being diagnosed. But in Israel, 20 percent of ALS patients survive longer. The high survival rate is thought to be due to family support systems, the Israeli health care system and early diagnosis.
(link expired)
(link should work)
Brainstorm completes stem cell bioreactor
Israel’s BrainStorm, together with Canadian company Octane Biotech, has built a bioreactor for commercial production of the stem cells used as a basis for the company's treatment for ALCS. The ability to multiply stem cells is critical for the treatment's success.
Israeli scientist leads search for Ebola cure
Virologist Dr. Leslie Lobel from Ben Gurion University is developing a vaccine to defeat the Ebola virus by studying the immune systems of the disease’s survivors. He has spent 12 years studying the disease in Uganda.
New pancreatic cancer treatment is now Israeli
Normally, foreign investors acquire Israeli biotechs that develop cancer treatments. But here, Israel’s Redhill Biopharma has bought pancreatic cancer treatment RP101 from Germany’s RESprotect GmbH. RP101 has passed Phase II trials and has vital orphan status.
Revolutionary device for hip replacements
Israel’s MMATech Ltd develops components for total hip implants, made of a revolutionary Polyimide material, MP1 developed originally for the aerospace industry. They are self-lubricating, durable, and have a long lifespan. MMATech is raising funds for FDA approval.
Live longer in Israel
In the last decade, mortality rates have plummeted, especially for cancer, strokes, respiratory disease and diabetes. Life is more healthy here than in the USA and Europe.
GE selects heart-attack prevention watch
Israeli start-up Oxitone literally keeps a “watch” on blood-oxygen levels affecting the heart. Two optical lasers are built into an oximeter that sits on the wrist. GE Healthcare chose Oxitone from 400 companies and is the only foreign company to join GE’s entrepreneur program.